In conclusion, this study demonstrates the coexistence of increased plasma DPP4 concentration and DPP4 enzymatic activity in patients with NAFLD, with and without obesity and metabolic disorders. The gene discussed is DPP4; the disease is metabolic dysfunction-associated steatotic liver disease.